PBM Alliance with Walgreens seeks to lower drug costs, improve outcomes

Published Online: Sep 01,2016 Laurie Toich, Assistant Editor Drug costs have become a hot button issue throughout the healthcare and pharmaceutical industries, as patient outcomes and value-based care take center stage. The US Centers for Medicare and Medicaid Services has focused on both aspects of healthcare through proposed rules and payment models, among other cost-controlling actions. Executives at Prime Therapeutics, a …

Rising costs may not be a result of orphan drugs

Published Online: Sep 12,2016 Laurie Toich, Assistant Editor From Daraprim’s price rising 5556% by Turing Pharmaceuticals under the leadership of Martin Shkreli, to the most recent pricing scandal with Mylan’s EpiPen, Americans have been faced with high out-of-pocket costs for many prescription drugs. Government institutions, such as the US Centers for Medicare and Medicaid, have begun crafting novel ways to reduce …

How will the changes to Medicare Part D impact you?

  In this presentation given by Mike Anderson, Pharm.D, Chief Pharmacy Officer, UnitedHealthcare Medicare & Retirement at Market Access USA, he highlights the demographic, regulatory and marketplace changes to Medicare Part D and how they will impact you. Download this presentation and learn: Overview of UnitedHealth Group Demographic Changes Regulatory Changes Marketplace Changes Download the presentation now To learn more …